Trial Profile
A Phase 1, Randomized, Cross-over, Two-period Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2018
Price :
$35
*
At a glance
- Drugs Cotadutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MedImmune
- 13 Feb 2018 Status changed from active, no longer recruiting to completed.
- 08 Jan 2018 Planned End Date changed from 1 Feb 2018 to 24 Jan 2018.
- 08 Jan 2018 Planned primary completion date changed from 1 Feb 2018 to 24 Jan 2018.